This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Trophogen Inc.. Active years: 2013-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2020
Title: Mariusz Szkudlinski: Innovator in Glycoprotein Hormone Research
Introduction
Mariusz Szkudlinski is a prominent inventor based in Rockville, MD (US), known for his significant contributions to the field of glycoprotein hormone research. With a total of 8 patents to his name, Szkudlinski has made remarkable advancements that have the potential to impact medical treatments significantly.
Latest Patents
One of Szkudlinski's latest patents focuses on glycoprotein hormone long-acting superagonists. This invention provides long-acting, superactive analogs of glycoprotein hormones that demonstrate enhanced bioactivity both in vitro and in vivo compared to their wild type counterparts. These analogs are particularly useful for treating subjects with low receptor expression or poor receptor responsiveness, as well as for addressing any condition associated with glycoprotein hormone activity.
Career Highlights
Szkudlinski has established himself as a key figure in his field, working at Trophogen Inc., where he continues to innovate and develop new therapeutic solutions. His work has garnered attention for its potential to improve treatment outcomes for various medical conditions.
Collaborations
Szkudlinski collaborates with notable professionals in his field, including his coworker Bruce D Weintraub. Their combined expertise contributes to the advancement of research and development in glycoprotein hormone therapies.
Conclusion
Mariusz Szkudlinski's innovative work in glycoprotein hormone research exemplifies the impact of dedicated inventors in the medical field. His contributions continue to pave the way for new treatments that can enhance patient care and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
